Atnaujinkite slapukų nuostatas

El. knyga: Chronic Myeloid Leukemia: A Handbook for Hematologists and Oncologists

(Tufts University Medical Center, Boston, Massachusetts, USA, Kings College NHS Foundation Trust, London, and University of Buckingham Medical School, UK)
  • Formatas: 143 pages
  • Išleidimo metai: 25-Apr-2013
  • Leidėjas: CRC Press
  • Kalba: eng
  • ISBN-13: 9781842145784
Kitos knygos pagal šią temą:
  • Formatas: 143 pages
  • Išleidimo metai: 25-Apr-2013
  • Leidėjas: CRC Press
  • Kalba: eng
  • ISBN-13: 9781842145784
Kitos knygos pagal šią temą:

DRM apribojimai

  • Kopijuoti:

    neleidžiama

  • Spausdinti:

    neleidžiama

  • El. knygos naudojimas:

    Skaitmeninių teisių valdymas (DRM)
    Leidykla pateikė šią knygą šifruota forma, o tai reiškia, kad norint ją atrakinti ir perskaityti reikia įdiegti nemokamą programinę įrangą. Norint skaityti šią el. knygą, turite susikurti Adobe ID . Daugiau informacijos  čia. El. knygą galima atsisiųsti į 6 įrenginius (vienas vartotojas su tuo pačiu Adobe ID).

    Reikalinga programinė įranga
    Norint skaityti šią el. knygą mobiliajame įrenginyje (telefone ar planšetiniame kompiuteryje), turite įdiegti šią nemokamą programėlę: PocketBook Reader (iOS / Android)

    Norint skaityti šią el. knygą asmeniniame arba „Mac“ kompiuteryje, Jums reikalinga  Adobe Digital Editions “ (tai nemokama programa, specialiai sukurta el. knygoms. Tai nėra tas pats, kas „Adobe Reader“, kurią tikriausiai jau turite savo kompiuteryje.)

    Negalite skaityti šios el. knygos naudodami „Amazon Kindle“.

Highly Commended, BMA Medical Book Awards 2014

Chronic myeloid leukemia is a clonal disease that results from an acquired genetic change in a single pluripotential hemopoietic stem cell. Efforts to confront this disease have been assisted by advances in cellular and molecular biology and the speed at which these findings have transformed the therapeutic algorithm. Nevertheless, there is some uncertainty with regards to how best to assess efficacy of treatment, especially with regards to the most appropriate surrogate markers for overall survival. From the standpoint of biology and clinical management, this handbook provides an authoritative state-of-the-art review of current and developing progress.

Recenzijos

"In this volume, Dr. Tariq Mughal chronicles the history of this field and provides succinct and reasoned analyses of the current treatment approaches and controversies in CML. Both the general practitioner and the specialist will find much of value herein." Richard Van Etten, M.D., Ph.D., Tufts Medical Center, Boston, Massachusetts, USA

" a comprehensive yet highly readable text on CML. It includes historical reference, clinical pearls, molecular biology, and common sense in a clear, organized manner. You will even find inclusion of the humanities (references to history and literature!) and humor, all of which so sadly missing from most scholarly works. Reader, do not waste your time jumping from one internet link to another, trying to distinguish fact from fiction, and organizing the information into digestible content. Find a nice chair, a good light, and enjoy-Dr. Mughal has done the work for you. All you need to do is read, learn, and transmit your new knowledge to your patients care." Jerry Radich M.D., Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

"This is a fantastic book." Professor Rüdiger Hehlmann, Medizinische Fakultät Mannheim der Universität Heidelberg, Germany

"Professor Mughal is a world renowned leader in the field of the molecular pathogenesis and therapy of chronic myeloid leukemia (CML). This illustrative handbook provides essential insights into the paradigmatic role of CML research in guiding the inception and maintenance of molecularly targeted therapy. The robust genetic dissection of chronic myeloid leukemic blastic transformation and therapeutic resistance has informed the development of diagnostic and prognostic tools as well as therapeutic strategies that reach far beyond CML to a broad array of recalcitrant malignancies. Enjoy!" Catriona Jamieson, M.D., Ph.D., UCSD Cancer Center, La Jolla, California, USA

" a remarkable effort which summarizes the current state-of-affairs. I recommend it very highly. " Professor Tiziano Barbui, Bergamo, Italy

"an excellent overview of the biology and management of an important disease that provides a paradigm for the targeted management of other haematological and oncologic disorders. Highly Commended." 2014 BMA Medical Book Awards In this volume, Dr. Tariq Mughal chronicles the history of this field and provides succinct and reasoned analyses of the current treatment approaches and controversies in CML. Both the general practitioner and the specialist will find much of value herein. Richard Van Etten, M.D., Ph.D., Tufts Medical Center, Boston, Massachusetts, USA

a comprehensive yet highly readable text on CML. It includes historical reference, clinical pearls, molecular biology, and common sense in a clear, organized manner. You will even find inclusion of the humanities (references to history and literature!) and humor, all of which so sadly missing from most scholarly works. Reader, do not waste your time jumping from one internet link to another, trying to distinguish fact from fiction, and organizing the information into digestible content. Find a nice chair, a good light, and enjoy-Dr. Mughal has done the work for you. All you need to do is read, learn, and transmit your new knowledge to your patients care. Jerry Radich M.D., Fred Hutchinson Cancer Research Center, Seattle, Washington, USA

"This is a fantastic book." Professor Rüdiger Hehlmann, Medizinische Fakultät Mannheim der Universität Heidelberg, Germany

Professor Mughal is a world renowned leader in the field of the molecular pathogenesis and therapy of chronic myeloid leukemia (CML). This illustrative handbook provides essential insights into the paradigmatic role of CML research in guiding the inception and maintenance of molecularly targeted therapy. The robust genetic dissection of chronic myeloid leukemic blastic transformation and therapeutic resistance has informed the development of diagnostic and prognostic tools as well as therapeutic strategies that reach far beyond CML to a broad array of recalcitrant malignancies. Enjoy! Catriona Jamieson, M.D., Ph.D., UCSD Cancer Center, La Jolla, California, USA

a remarkable effort which summarizes the current state-of-affairs. I recommend it very highly." Professor Tiziano Barbui, Bergamo, Italy

"an excellent overview of the biology and management of an important disease that provides a paradigm for the targeted management of other haematological and oncologic disorders. Highly Commended." 2014 BMA Medical Book Awards

Acknowledgments iv
Preface vi
Foreword vii
John Goldman
Foreword ix
Giuseppe Saglio
1 An introduction to chronic myeloid leukemia
1(9)
2 A historical perspective of chronic myeloid leukemia
10(10)
3 Cytogenetics, molecular anatomy, and molecular biology of chronic myeloid leukemia
20(10)
4 Clinical aspects, prognostic and predictive factors
30(17)
5 Primary treatment of chronic myeloid leukemia
47(26)
6 Secondary treatment and stem cell transplantation for chronic myeloid leukemia
73(11)
7 Emerging and investigational treatment for chronic myeloid leukemia
84(9)
8 Definitions of response and monitoring response for patients with chronic myeloid leukemia
93(15)
9 Resistance to tyrosine kinase inhibitors and novel insights into genomic instability of chronic myeloid leukemia stem cells
108(10)
10 Concluding thoughts
118(7)
Bibliography 125(4)
Index 129
Tariq I. Mughal